196 related articles for article (PubMed ID: 28510158)
1. Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals.
Yadav S; Liu J; Scherer TM; Gokarn Y; Demeule B; Kanai S; Andya JD; Shire SJ
Biophys Rev; 2013 Jun; 5(2):121-136. PubMed ID: 28510158
[TBL] [Abstract][Full Text] [Related]
2. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
Liu J; Nguyen MD; Andya JD; Shire SJ
J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
[TBL] [Abstract][Full Text] [Related]
3. Analytical Ultracentrifugation and Its Role in Development and Research of Therapeutical Proteins.
Liu J; Yadav S; Andya J; Demeule B; Shire SJ
Methods Enzymol; 2015; 562():441-76. PubMed ID: 26412663
[TBL] [Abstract][Full Text] [Related]
4. A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies.
Esfandiary R; Hayes DB; Parupudi A; Casas-Finet J; Bai S; Samra HS; Shah AU; Sathish HA
J Pharm Sci; 2013 Sep; 102(9):3089-99. PubMed ID: 23794522
[TBL] [Abstract][Full Text] [Related]
5. Technical Decision-Making with Higher Order Structure Data: Detecting Reversible Concentration-Dependent Self-Association in a Monoclonal Antibody and a Preliminary Investigation to Eliminate It.
Wei JY; Bou-Assaf GM; Houde D; Weiskopf A
J Pharm Sci; 2015 Nov; 104(11):3984-3989. PubMed ID: 26308556
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
[TBL] [Abstract][Full Text] [Related]
7. Analytical ultracentrifugation for the study of protein association and assembly.
Howlett GJ; Minton AP; Rivas G
Curr Opin Chem Biol; 2006 Oct; 10(5):430-6. PubMed ID: 16935549
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
9. Determination of the SLAMF1 self-association affinity constant with sedimentation velocity ultracentrifugation.
Wei Y; Lee J; Dziegelewski M; Marlow MS; Hayes DB
Anal Biochem; 2021 Nov; 633():114410. PubMed ID: 34634259
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Native Reversible Self-Association of a Monoclonal Antibody Mediated by Fab-Fab Interaction.
Gentiluomo L; Roessner D; Streicher W; Mahapatra S; Harris P; Frieß W
J Pharm Sci; 2020 Jan; 109(1):443-451. PubMed ID: 31563513
[TBL] [Abstract][Full Text] [Related]
11. Full-length recombinant antibodies from
Rashid MH
MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
[TBL] [Abstract][Full Text] [Related]
12. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
[TBL] [Abstract][Full Text] [Related]
13. Cluster Size and Quinary Structure Determine the Rheological Effects of Antibody Self-Association at High Concentrations.
Wang W; Lilyestrom WG; Hu ZY; Scherer TM
J Phys Chem B; 2018 Feb; 122(7):2138-2154. PubMed ID: 29359938
[TBL] [Abstract][Full Text] [Related]
14. Biophysical characterization of a model antibody drug conjugate.
Arakawa T; Kurosawa Y; Storms M; Maruyama T; Okumura CJ; Maluf NK
Drug Discov Ther; 2016; 10(4):211-7. PubMed ID: 27534450
[TBL] [Abstract][Full Text] [Related]
15. A therapeutic antibody and its antigen form different complexes in serum than in phosphate-buffered saline: a study by analytical ultracentrifugation.
Demeule B; Shire SJ; Liu J
Anal Biochem; 2009 May; 388(2):279-87. PubMed ID: 19289095
[TBL] [Abstract][Full Text] [Related]
16. Interaction studies of a protein and carbohydrate system using an integrated approach: a case study of the miniagrin-heparin system.
Patel TR; Besong TMD; Meier M; McEleney K; Harding SE; Winzor DJ; Stetefeld J
Eur Biophys J; 2018 Oct; 47(7):751-759. PubMed ID: 29532137
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
18. Characterization of outcomes of amino acid modifications using a combinatorial approach to reveal physical and structural perturbations: A case study using trastuzumab biosimilar.
Kamble R; Puranik A; Narvekar A; Dandekar P; Jain R
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1209():123430. PubMed ID: 35988497
[TBL] [Abstract][Full Text] [Related]
19. Quantifying Trace Amounts of Aggregates in Biopharmaceuticals Using Analytical Ultracentrifugation Sedimentation Velocity: Bayesian Analyses and F Statistics.
Wafer L; Kloczewiak M; Luo Y
AAPS J; 2016 Jul; 18(4):849-60. PubMed ID: 27184576
[TBL] [Abstract][Full Text] [Related]
20. Both Reversible Self-Association and Structural Changes Underpin Molecular Viscoelasticity of mAb Solutions.
Sarangapani PS; Weaver J; Parupudi A; Besong TMD; Adams GG; Harding SE; Manikwar P; Castellanos MM; Bishop SM; Pathak JA
J Pharm Sci; 2016 Dec; 105(12):3496-3506. PubMed ID: 27793346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
